Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Rhea Healthcare Private Limited is a healthcare company that specializes in providing comprehensive medical services and solutions. It offers a range of services including diagnostics, telemedicine, and health management systems, aimed at enhancing patient care and streamlining healthcare operations throughout India.
Rhea Healthcare Private Limited, is an unlisted private company incorporated on 14 May, 2008. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 272.42 cr and the total paid-up capital is INR 1.09 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Venkatraman Vijayarathna
Shareholder
|
05323733 | 2 years |
| Nominee Director | Mayank Rawat | 06528218 | 4 years |
| Nominee Director | Bhushan Sudhir Bopardikar | 09089555 | 5 years |
| Nominee Director | Vishal Bali
Shareholder
|
01457380 | 9 years |
| Director | Ankur Nand Thadani | 03566737 | 9 years |
| Director | Ritesh Pandey
Shareholder
|
07088000 | 6 years |
| Director | Kumar Shobhit Agarwal
Shareholder
|
06700803 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | 236.2 | 268.7 | 353.7 | 492.6 | 999.7 |
| Operating profit | -24.7 | 21.7 | 42.6 | 74.5 | 150.3 |
| Net profit | -46.4 | -42.4 | -26.9 | -13.4 | 60.2 |
| Gross margin | 81.4 | 83.1 | 83.0 | 85.3 | 84.4 |
| Operating margin | -10.5 | 8.1 | 12.1 | 15.1 | 15.0 |
| Net margin | -19.4 | -15.5 | -7.5 | -2.7 | 5.7 |
| Networth | -1.5 | 13.4 | 38.7 | 91.8 | 335.8 |
| Borrowings | 115.4 | 113.8 | 143.0 | 128.7 | 191.6 |
| Assets | 187.4 | 368.5 | 519.3 | 608.1 | 1,156.3 |
| Debt to equity | -78.0 | 8.5 | 3.7 | 1.4 | 0.6 |
| Current ratio | 0.5 | 0.9 | 0.6 | 0.6 | 0.8 |
| ROE | - | -316.4 | -69.5 | -14.6 | 17.9 |
| Days payable | 273.0 | 287.0 | 291.0 | 302.0 | 265.0 |
| WC days | -69.0 | -9.0 | -49.0 | -38.0 | -22.0 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 0.4 | 0.5 | 0.5 | 0.5 | 1.1 |
| Reserves | -1.9 | 12.9 | 38.2 | 91.3 | 334.8 |
| Borrowings + | 115.4 | 113.8 | 143.0 | 128.7 | 191.6 |
| Long term borrowings | 90.4 | 82.5 | 87.0 | 87.7 | 140.6 |
| Short term borrowings | 24.9 | 31.3 | 56.0 | 41.1 | 51.0 |
| Trade payables + | 32.9 | 35.7 | 48.0 | 60.1 | 113.2 |
| Days payable | 273.0 | 287.0 | 291.0 | 302.0 | 265.0 |
| Other liabilities + | 73.5 | 241.3 | 337.5 | 387.6 | 628.9 |
| Other non-current liabilities | 18.5 | 191.2 | 261.7 | 294.5 | 431.6 |
| Other current liabilities | 22.1 | 14.4 | 27.8 | 32.9 | 84.0 |
| Total liabilities | 187.4 | 368.5 | 519.3 | 608.1 | 1,156.3 |
| Fixed Assets + | 105.7 | 270.4 | 340.2 | 390.7 | 609.7 |
| Tangible assets | 105.0 | 267.5 | 334.0 | 384.1 | 589.6 |
| CWIP | - | 1.1 | 4.3 | 5.2 | 14.4 |
| Intangible assets | 0.7 | 1.9 | 2.0 | 1.3 | 5.7 |
| LT loans and advances | 35.9 | - | - | - | 3.2 |
| Other non-current assets | 10.2 | 23.5 | 95.1 | 134.5 | 354.2 |
| Current assets + | 35.6 | 74.6 | 83.9 | 82.9 | 189.2 |
| Inventories | 4.6 | 3.6 | 5.8 | 6.7 | 14.6 |
| Trade receivables | 8.5 | 5.4 | 9.4 | 12.9 | 15.2 |
| Cash and cash equivalents | 10.9 | 2.3 | 0.7 | 0.9 | 10.6 |
| ST loans and advances | 9.4 | - | 6.6 | 2.5 | - |
| Other current assets | 2.2 | 63.3 | 61.4 | 60.0 | 148.8 |
| Total assets | 187.4 | 368.5 | 519.3 | 608.1 | 1,156.3 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | 236.2 | 268.7 | 353.7 | 492.6 | 999.7 |
| Sales growth % | 52.46 | 13.73 | 31.65 | 39.27 | 102.97 |
| Expenses + | 300.8 | 315.5 | 385.9 | 511.3 | 1,007.5 |
| Cost of goods | 44.0 | 45.5 | 60.3 | 72.6 | 156.2 |
| Employee cost | 57.8 | 45.3 | 53.9 | 75.8 | 173.1 |
| Other costs | 159.1 | 156.1 | 196.9 | 269.7 | 520.1 |
| Operating profit + | -24.7 | 21.7 | 42.6 | 74.5 | 150.3 |
| Operating margin % | -10.5 | 8.1 | 12.1 | 15.1 | 15.0 |
| Other income | 2.4 | 4.5 | 5.4 | 5.3 | 59.9 |
| Interest | 15.4 | 31.3 | 35.5 | 42.3 | 64.9 |
| Depreciation | 24.5 | 37.3 | 39.4 | 51.0 | 93.2 |
| Exceptional items | 15.8 | - | - | - | 8.0 |
| Profit before tax | -46.4 | -42.4 | -26.9 | -13.4 | 60.2 |
| Tax | - | - | - | - | - |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | -46.4 | -42.4 | -26.9 | -13.4 | 60.2 |
| Net margin % | -19.4 | -15.5 | -7.5 | -2.7 | 5.7 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | -78.0 | 8.5 | 3.7 | 1.4 | 0.6 |
| Net Debt/Equity | -70.6 | 8.3 | 3.7 | 1.4 | 0.5 |
| Total Debt/Assets | 0.6 | 0.3 | 0.3 | 0.2 | 0.2 |
| Total Assets/Equity | -126.7 | 27.5 | 13.4 | 6.6 | 3.4 |
| Liquidity + | |||||
| Current Ratio | 0.5 | 0.9 | 0.6 | 0.6 | 0.8 |
| Quick Ratio | 0.4 | 0.9 | 0.6 | 0.6 | 0.7 |
| Interest Coverage | -1.6 | 0.7 | 1.2 | 1.8 | 2.3 |
| Performance | |||||
| Gross Margin | 81.4 | 83.1 | 83.0 | 85.3 | 84.4 |
| Operating Margin | -10.5 | 8.1 | 12.1 | 15.1 | 15.0 |
| Net Margin | -19.4 | -15.5 | -7.5 | -2.7 | 5.7 |
| Return + | |||||
| Return on Equity | - | -316.4 | -69.5 | -14.6 | 17.9 |
| Pre-tax ROCE | -80.2 | -5.9 | 1.1 | 6.9 | 10.4 |
| Return on Assets | -24.8 | -11.5 | -5.2 | -2.2 | 5.2 |
| Pre-tax ROIC | -47.8 | -12.5 | 1.8 | 10.7 | 11.1 |
| Efficiency + | |||||
| Days Payable | 273.0 | 287.0 | 291.0 | 302.0 | 265.0 |
| Days Inventory | 38.0 | 29.0 | 35.0 | 34.0 | 34.0 |
| Days Receivable | 13.0 | 7.0 | 10.0 | 10.0 | 6.0 |
| Fixed Asset Turnover | 2.2 | 1.0 | 1.0 | 1.3 | 1.6 |
| Total Asset Turnover | 1.3 | 0.7 | 0.7 | 0.8 | 0.9 |
| Working Capital | |||||
| Cash Conversion Cycle | -222.0 | -251.0 | -246.0 | -258.0 | -225.0 |
| Working Capital Days | -69.0 | -9.0 | -49.0 | -38.0 | -22.0 |
HDFC Bank Limited
No. of Loans: 4
Total Amount : 231.0 cr
ICICI Bank Limited
No. of Loans: 2
Total Amount : 120.0 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 28.4 cr
VISTRA ITCL (INDIA) LIMITED
No. of Loans: 2
Total Amount : 3.5 cr
Vistra ITCL (India) Limited
No. of Loans: 1
Total Amount : 0.3 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| MESKHENET HEALTHCARE PRIVATE LIMITED | Chandigarh | 2021 | ₹ 74.0 Cr |
| CHAITHANYA INTEGRATED HEALTHCARE (INDIA) PRIVATE LIMITED | Karnataka | 2008 | ₹ 2.0 Cr |
| Nova Fertility East Private Limited | India | - | - |
| NOVA PULSE IVF CLINIC AHMEDABAD PRIVATE LIMITED | Maharashtra | 2003 | ₹ 75,500.0 |
| REVABA INFERTILITY CLINICS PRIVATE LIMITED | Gujarat | 2017 | ₹ 1.2 L |
| SVAS MED PRIVATE LIMITED | Delhi | 2010 | ₹ 7.5 L |
| ORIGIN INTERNATIONAL FERTILITY CENTRE PRIVATE LIMITED | Maharashtra | 2007 | ₹ 1.0 L |
Read more
The incorporation date of RHEA HEALTHCARE PRIVATE LIMITED is 14 May, 2008
The authorized share capital of RHEA HEALTHCARE PRIVATE LIMITED is INR ₹ 272.4 Cr.
The paid-up capital of RHEA HEALTHCARE PRIVATE LIMITED is INR ₹ 1.1 Cr.
The registered address of RHEA HEALTHCARE PRIVATE LIMITED is 7A, 9th Floor Pinnacle Corporate Park, Bldg No.19 A Wing, G-Block, Bandra Kurla Complex, B, andra East, Mumbai City, Mumbai, Maharashtra, India, 400051 - 400051
The CIN number of RHEA HEALTHCARE PRIVATE LIMITED is U85110MH2008PTC375300.